INOVIO FORMS ASIAN SUBSIDIARY IN SINGAPORE

US-based Inovio Biomedical Corporation, late stage developer of therapies for cancer and other applications using electroporation to deliver drugs and nucleic acids, will establish Inovio Asia Pte Ltd., a majority-owned subsidiary in the Republic of Singapore, with the goal of pursuing business and scientific development opportunities in the east Asian marketplace. BioSpectrum (http://www.biospectrumasia.com/content/190906SGP1666.asp)